These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


806 related items for PubMed ID: 29641576

  • 1. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM, Sachdeva KS, Dewan PK, Rade K, Nair SA, Pant R, Khaparde SD.
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [Abstract] [Full Text] [Related]

  • 2. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
    Yuen CM, Kurbatova EV, Tupasi T, Caoili JC, Van Der Walt M, Kvasnovsky C, Yagui M, Bayona J, Contreras C, Leimane V, Ershova J, Via LE, Kim H, Akksilp S, Kazennyy BY, Volchenkov GV, Jou R, Kliiman K, Demikhova OV, Vasilyeva IA, Dalton T, Cegielski JP.
    PLoS Med; 2015 Dec; 12(12):e1001932. PubMed ID: 26714320
    [Abstract] [Full Text] [Related]

  • 3. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M, Bashir A, Ahmad N, Fatima RK, Saba S, Scahill S.
    BMC Infect Dis; 2017 Sep 29; 17(1):655. PubMed ID: 28962599
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S.
    Int J Tuberc Lung Dis; 2016 Dec 29; 20(12):1671-1676. PubMed ID: 27931345
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.
    Am J Ther; 2011 Sep 29; 18(5):343-9. PubMed ID: 20535008
    [Abstract] [Full Text] [Related]

  • 9. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 29; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 10. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K, Saini V, Dhillon R, Agarwal P.
    Indian J Tuberc; 2019 Apr 29; 66(2):247-252. PubMed ID: 31151492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.
    Ann Intern Med; 2006 May 02; 144(9):650-9. PubMed ID: 16670134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India.
    Muniyandi M, Ramachandran R.
    Expert Opin Pharmacother; 2017 Sep 02; 18(13):1301-1309. PubMed ID: 28786691
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.